Corporate Advisors
Karl F. Popp, R. Ph.
Karl Popp founded KPopp Consulting, LLC in 2010 as a consulting firm providing services to pharmaceutical, cosmetic and allied industries. He is licensed to practice pharmacy in New York.
During his career he has been responsible for the development of products that have generated over $2 billion in sales.
From 1989 to 2008 he was associated with Stiefel Laboratories as Director of Product Development, and later as Senior Director of Special Projects coordinating external manufacturing, global research activities, and managing the corporation's intellectual property estate.
Prior to joining Stiefel in 1989, he was a Scientist and Project Manager for the Sterling-Winthrop Research Group. He earned his B. S. in Pharmacy from the Albany College of Pharmacy, an M.B.A. from Rensselaer Polytechnic Institute and is licensed to practice pharmacy in NY.
He has been active in the SCC in coordinating local educational seminars and served as the local chairperson (2013), served on the National Committee on Scientific Affairs (1994-96), as Vice President-Elect (1997), Vice President (1998), and as the Society's President in 1999. Karl was elected a Fellow of the Society in 2002. He is an inventor, an author and a scientist.
Karl Popp has lectured around the globe on new product development activities, GMPs and process validation, product life cycle management, and management of intellectual property. He has also served as an expert witness in matters before the U.S. federal courts.
Darryl G. Cleary, Ph.D.
From 2005 to 2012, Dr. Cleary was the Vice President of Manufacturing for Pharmasset Inc. The majority of Dr. Cleary's efforts were focused upon the pharmaceutical development of the Hepatitis C drug GS-7977 (Sofosbuvir), where his responsibilities included site selection, contract & timeline negotiations and subsequent oversight & management of the production of rapidly increasing quantities of all cGMP intermediates, API and final dosage forms.
From 2001 to 2005, Dr. Cleary owned and operated a successful consulting business providing services to the pharmaceutical industry including; sourcing, chain-supply development and expansion, chemical development, process optimization & scale-up and formulations development.
From 1996 to 2001, Dr. Cleary was employed by Triangle Pharmaceuticals as a Senior Chemist. In the early years, he worked on & contributed to the chemical development of Emtricitibine, Amdoxovir & Coactinon anti-virals. In the later years he expanded into supply chain development and outsourcing.
Dr. Cleary's first job in the pharmaceutical industry was as a medicinal chemist for Burroughs Wellcome where he worked on the synthesis of novel anti-viral compounds.
Dr. Cleary earned his Ph.D. in 1985 from the University of South Carolina. He studied and worked in the research group of Professor James Marshall and his dissertation included the synthesis of Asperdiol; a 14-membered ring containing Cembrane natural product.
Frank Hauser, Ph.D.
Dr. Hauser received both his B.S. and Ph.D. in Chemistry from the University of North Carolina then did post-doctoral research at Iowa State and The Research Triangle Institute before joining the The Research Triangle as a research scientist. In 1974, he moved to the Oregon Graduate as an associate professor and was promoted to full professor in 1980. In 1986, he moved to the State University of New York at Albany.
Professor Hauser has served on numerous federal panels, including Child Health and Human Development, Medicinal Chemistry and Small Business Program. In addition, he has given numerous lectures at academic institutions and pharmaceutical companies.
His primary research interest has been the development of new synthetic methods for the synthesis of biologically important natural products, To this end, he has developed methods for regiospecific synthesis of benzenoid and higher polycyclic systems, the isolation, structure elucidation of amaryllidaceae alkaloids and other natural products and routes for total synthesis of C-Arylglycosides. Specific classes of compounds include: anthracycline antibiotics, amino sugars, morphine alkaloids, steroids, prostaglandins and cannabinoids.
